7 is better than 5
they have reduced 40% because management has decided to prepare for the worse,any positive move by fda will make aria fly high.Next week should be great for me.
These are the catalysts that may occur in near future : zurich study for type one diabetes ,novartis trial results may add to xoma value,Phizer still working with fda on tanezumab,maybe it's not dead.
short=fried turkey this hanukkasgiving
blod clot causes by canser ---somebody wants aria at 2 billion?!I feel sorry for the system of greed,it's the world where we live today.Greedy rules,buy aria-get greedy!!!
Venous thrombosis can occur in the deep veins of the extremities, referred to as deep vein thrombosis (DVT ), or in the lungs, referred to as pulmonary embolism (PE ). Taken together, DVT /PE are commonly referred to as venous thromboembolism or VTE . Approximately 20% of all VTE s occur in patients with cancer1. The risk for VTE in cancer is determined by a number of co-existing factors which may be broadly divided into general risk factors [age, race, obesity, past history of VTE , coexisting medical conditions, inherited and acquired thrombophilias] and cancer specific risk factors [cancer site, stage, type of chemotherapy, hormonal therapy, surgery].
FDA is helping big pharma to take aria cheap.Buy aria,it's a gift like a ford at 1$ or LVS at 1.50.
rise in leukemia cases drives docs crazy,it's a catastrophic event,in the hands of a big pharma drug will be tested again,they have another drug in their pipeline: AP...,-golden egg-,big pharma is looking into aria,it's a small company,but not really,yes ,mistakes been done but big pharma will fix it and profit from it big time,2 billion =pennies for them.Just watch.